Role of methotrexate in biologics use with psoriasis and psoriatic arthritis
Biologic agents have significantly improved treatment outcomes for psoriasis and psoriatic arthritis (PsA). However, their long-term effectiveness can decline due to the formation of anti-drug antibodies. The off-label addition of methotrexate (MTX) to biologics offers benefits through synergistic a...
Saved in:
| Main Authors: | Ting-Ting Cheng, Yang Lo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Dermatologica Sinica |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ds.DS-D-24-00194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of methotrexate in the treatment of psoriasis and psoriatic arthritis
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-06-01) -
Comparative study of Methotrexate and Cyclosporine in the treatment of Psoriasis
by: D Karn, et al.
Published: (2012-01-01) -
Comparative study of Methotrexate and Cyclosporine in the treatment of Psoriasis
by: D Karn, et al.
Published: (2012-01-01) -
Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis
by: I. M. Marusenko, et al.
Published: (2019-03-01) -
Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2016-09-01)